Swedencare AB (publ) (SECARE.ST)

SEK 38.85

(0.65%)

Inventory Summary of Swedencare AB (publ)

Swedencare AB (publ)'s latest annual inventory in 2023 was 398.1 Million SEK , down -9.84% from previous year.
Swedencare AB (publ)'s latest quarterly inventory in 2024 Q3 was 450.7 Million SEK , down -7.07% from previous quarter.
Swedencare AB (publ) reported annual inventory of 441.53 Million SEK in 2022, up 178.92% from previous year.
Swedencare AB (publ) reported annual inventory of 158.29 Million SEK in 2021, up 156.18% from previous year.
Swedencare AB (publ) reported quarterly inventory of 450.7 Million SEK for 2024 Q3, down -7.07% from previous quarter.
Swedencare AB (publ) reported quarterly inventory of 485 Million SEK for 2024 Q2, up 3.24% from previous quarter.

Annual Inventory Chart of Swedencare AB (publ) (2023 - 2013)

Historical Annual Inventory of Swedencare AB (publ) (2023 - 2013)

Year	Inventory	Inventory Growth
2023	398.1 Million SEK	-9.84%
2022	441.53 Million SEK	178.92%
2021	158.29 Million SEK	156.18%
2020	61.79 Million SEK	304.0%
2019	15.29 Million SEK	57.03%
2018	9.74 Million SEK	18.28%
2017	8.23 Million SEK	11.94%
2016	7.35 Million SEK	133.78%
2015	3.14 Million SEK	101.73%
2014	1.56 Million SEK	-15.64%
2013	1.84 Million SEK	0.0%

Year	Inventory	Inventory Growth
2024 Q1	469.8 Million SEK	18.01%
2024 Q3	450.7 Million SEK	-7.07%
2024 Q2	485 Million SEK	3.24%
2023 Q1	443 Million SEK	0.33%
2023 Q4	398.1 Million SEK	-9.25%
2023 FY	398.1 Million SEK	-9.84%
2023 Q3	438.7 Million SEK	-4.86%
2023 Q2	461.1 Million SEK	4.09%
2022 Q1	398.31 Million SEK	151.62%
2022 Q3	487.33 Million SEK	9.77%
2022 FY	441.53 Million SEK	178.92%
2022 Q2	443.96 Million SEK	11.46%
2022 Q4	441.53 Million SEK	-9.4%
2021 Q4	158.29 Million SEK	6.49%
2021 FY	158.29 Million SEK	156.18%
2021 Q3	148.65 Million SEK	41.4%
2021 Q2	105.12 Million SEK	18.83%
2021 Q1	88.46 Million SEK	43.17%
2020 Q3	31.25 Million SEK	83.39%
2020 FY	61.79 Million SEK	304.0%
2020 Q2	17.04 Million SEK	4.01%
2020 Q1	16.38 Million SEK	7.13%
2020 Q4	61.79 Million SEK	97.72%
2019 Q3	13.85 Million SEK	27.77%
2019 Q2	10.84 Million SEK	-2.12%
2019 FY	15.29 Million SEK	57.03%
2019 Q1	11.08 Million SEK	13.77%
2019 Q4	15.29 Million SEK	10.37%
2018 Q4	9.74 Million SEK	0.85%
2018 FY	9.74 Million SEK	18.28%
2018 Q3	9.65 Million SEK	8.52%
2018 Q2	8.9 Million SEK	-3.16%
2018 Q1	9.19 Million SEK	11.6%
2017 FY	8.23 Million SEK	11.94%
2017 Q2	8.47 Million SEK	18.56%
2017 Q3	9.57 Million SEK	12.96%
2017 Q4	8.23 Million SEK	-14.01%
2017 Q1	7.15 Million SEK	-2.8%
2016 Q1	3.23 Million SEK	2.86%
2016 Q4	7.35 Million SEK	127.7%
2016 Q3	3.23 Million SEK	17.28%
2016 Q2	2.75 Million SEK	-14.89%
2016 FY	7.35 Million SEK	133.78%
2015 FY	3.14 Million SEK	101.73%
2015 Q4	3.14 Million SEK	0.0%
2015 Q1	- SEK	0.0%
2014 FY	1.56 Million SEK	-15.64%
2013 FY	1.84 Million SEK	0.0%

Peer Inventory Comparison of Swedencare AB (publ)

Name	Inventory	Inventory Difference
AcuCort AB	-1.09 Million SEK	36323.84%
AlzeCure Pharma AB (publ)	-2508.00 SEK	15873305.742%
BioGaia AB (publ)	181.2 Million SEK	-119.697%
Enzymatica AB (publ)	11.49 Million SEK	-3362.04%
Enorama Pharma AB (publ)	4.29 Million SEK	-9175.396%
Gabather AB (publ)	-1772.00 SEK	22466239.955%
Klaria Pharma Holding AB (publ.)	- SEK	-Infinity%
Moberg Pharma AB (publ)	7.11 Million SEK	-5495.221%
Nanexa AB (publ)	1.91 Million SEK	-20732.025%
Newbury Pharmaceuticals AB (publ)	4.99 Million SEK	-7869.97%
ODI Pharma AB	- SEK	-Infinity%
Orexo AB (publ)	42.4 Million SEK	-838.915%
Probi AB (publ)	116.7 Million SEK	-241.116%
Swedish Orphan Biovitrum AB (publ)	3.87 Billion SEK	89.724%
Toleranzia AB	-1.34 Million SEK	29808.955%
Vivesto AB	- SEK	-Infinity%